The positive since relisting is that the stock has been...

The positive since relisting is that the stock has been significantly de-risked. Going concern issues are thankfully a thing of the past. They have also continued to move forward, some might argue not fast enough, but there is clearly growth in the value of the company. Gaining an EMI licence will further add value. The negative is that the SOH has increased. Another negative is that the level of analysis released to the market to date has been weak. The EMI licence appears to be a done deal, the new director seems to be a sound appointment. I expect positive results to start to flow through in the financials. Once they do, it will be too late, the price will be more than double what it is currently. It seems there are others who have come to the same conclusion with the recent rise in the share prices. I don't see 5 cents without the support of strong revenue growth but it could take off.